|
National Eye Institute (NEI)46 Protocols (37 Active Accrual of new subjects, 9 Follow-up of previously enrolled subjects)
-
04-EI-0260:
Use of Immune Cell Markers, Cytokines, and Transcription Factors as Markers of Intraocular Inflammatory Activity
-
04-EI-0241:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Anterior Segment Disease
-
04-EI-0240:
Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau Disease
-
04-EI-0190:
Pilot Study of Helicobacter Pylori and Ocular Surface Disease
-
04-EI-0166:
A Cross Sectional Clinical Study of Human Lens Aging and Cataract Formation, in Vivo, Using Dynamic Light Scattering (DLS)
-
04-EI-0157:
Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]
-
04-EI-0128:
Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System
-
04-EI-0115:
Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis
-
04-EI-0065:
Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis
-
04-EI-0048:
Digital Image Based Determination of Ocular Surface Vital Dye Staining
-
04-EI-0039:
Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Disease
-
04-EI-0006:
Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study
-
03-EI-0294:
Optical Coherence Tomography Comparative Study
-
03-EI-0275:
Pilot Study on the Use of the NASA-NEI Dynamic Light Scattering (DLS) Device in Detecting lens Changes in the other Eye of Patients with Pre-Senile Cataracts
-
03-EI-0255:
Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa
-
03-EI-0234:
A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Patients with Retinitis Pigmentosa
-
03-EI-0179:
Investigation of the Effect of Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Function in Subjects with Autosomal Dominant Stargardt-Like and Autosomal Recessive Stargardt Macular Dystrophy
-
03-EI-0156:
Measurement of Macular Pigment with Resonant Raman Backscattering Spectroscopy
-
03-EI-0155:
Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)
-
03-EI-0123:
Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts
-
03-EI-0068:
Identification of Biological Markers in Retinal Vasculitis
-
03-EI-0065:
Preliminary Multi-center Assessment of Laser and Medical Treatment of Diabetic Macular Edema
-
03-EI-0033:
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies
-
03-EI-0012:
A Pilot Study Using the Dynamic Light Scattering Device (DLS) Combined with Keratoscopy on the Cornea in Vivo
-
02-EI-0255:
Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors
-
01-EI-0102:
Evaluation and Treatment Protocol for Potential Research Subjects with Inherited Ophthalmic Diseases
-
01-EI-0046:
Evaluation and Treatment Protocol of Patients with Corneal and External Diseases
-
00-EI-0204:
Evaluation and Treatment Protocol for Patients with Intraocular Inflammatory Disease (Uveitis)
-
00-EI-0139:
Evaluation and Treatment Protocol for Patients with Retinal Disease
-
00-EI-0135:
Study of Association of Serum Factors with Diabetic Retinopathy
-
99-EI-0035:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Nystagmus or Strabismus
-
98-EI-0085:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Ocular Inflammatory or Immunologic Diseases
-
98-EI-0076:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Retinovascular Diseases
-
98-EI-0072:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Inherited Ophthalmic Diseases
-
92-EI-0113:
Immunopathology of Ocular Diseases in Humans
-
86-EI-0062:
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis
-
80-EI-0093:
Visual Motor Coordination in Man
-
04-EI-0223:
Efficacy of Elevated CD4 Cell Counts on CMV Retinitis
-
04-EI-0013:
Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders
-
03-EI-0291:
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
-
03-EI-0101:
Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease
-
02-EI-0257:
Multi-Center Randomized Phase I/II Trial to Study the Effects of Cyclooxygenase-2 Inhibition on the response to Photodynamic Therapy in Patients with Age-Related Macular Degeneration
-
02-EI-0242:
Evaluation of Subcutaneous Daclizumab Treatments in Patients with Non-infectious Sight-threatening Uveitis: A Multicenter, Open-Label, Phase II Study
-
01-EI-0208:
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration
-
96-EI-0096:
Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis with Humanized Anti-Tac Antibody Therapy
-
92-EI-0250:
Age-Related Eye Disease Study - Phase II
Search The Studies | Help | Questions
| Clinical Center Home | NIH Home
Warren Grant Magnuson Clinical Center (CC) National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/14/2004
|
|